MZPClass II
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
21 CFR 866.3170 / Microbiology
MZP is the FDA product code for Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus, a class II device type, regulated under 21 CFR 866.3170. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and 11 recalls.
Classification record
- Product code
- MZP
- Device name
- Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
- Regulation
- 21 CFR 866.3170
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 4
- Ingested recalls
- 11
Clearances, product code MZP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Applicants with the most clearances
Product code MZP| Applicant | Clearances |
|---|---|
| Roche Molecular Systems Inc | 2 |
| Abbott Molecular, Inc. | 1 |
| Hologic, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
